Participatory learning and action cycles with women's groups to prevent neonatal death in low-resource settings: A multi-country comparison of cost-effectiveness and affordability.
Costs
community mobilization
cost-effectiveness analysis
maternal and child health
randomized controlled trial
Journal
Health policy and planning
ISSN: 1460-2237
Titre abrégé: Health Policy Plan
Pays: England
ID NLM: 8610614
Informations de publication
Date de publication:
16 Feb 2021
16 Feb 2021
Historique:
accepted:
07
07
2020
pubmed:
22
10
2020
medline:
29
7
2021
entrez:
21
10
2020
Statut:
ppublish
Résumé
WHO recommends participatory learning and action cycles with women's groups as a cost-effective strategy to reduce neonatal deaths. Coverage is a determinant of intervention effectiveness, but little is known about why cost-effectiveness estimates vary significantly. This article reanalyses primary cost data from six trials in India, Nepal, Bangladesh and Malawi to describe resource use, explore reasons for differences in costs and cost-effectiveness ratios, and model the cost of scale-up. Primary cost data were collated, and costing methods harmonized. Effectiveness was extracted from a meta-analysis and converted to neonatal life-years saved. Cost-effectiveness ratios were calculated from the provider perspective compared with current practice. Associations between unit costs and cost-effectiveness ratios with coverage, scale and intensity were explored. Scale-up costs and outcomes were modelled using local unit costs and the meta-analysis effect estimate for neonatal mortality. Results were expressed in 2016 international dollars. The average cost was $203 (range: $61-$537) per live birth. Start-up costs were large, and spending on staff was the main cost component. The cost per neonatal life-year saved ranged from $135 to $1627. The intervention was highly cost-effective when using income-based thresholds. Variation in cost-effectiveness across trials was strongly correlated with costs. Removing discounting of costs and life-years substantially reduced all cost-effectiveness ratios. The cost of rolling out the intervention to rural populations ranges from 1.2% to 6.3% of government health expenditure in the four countries. Our analyses demonstrate the challenges faced by economic evaluations of community-based interventions evaluated using a cluster randomized controlled trial design. Our results confirm that women's groups are a cost-effective and potentially affordable strategy for improving birth outcomes among rural populations.
Identifiants
pubmed: 33085753
pii: 5934745
doi: 10.1093/heapol/czaa081
pmc: PMC7886438
doi:
Types de publication
Journal Article
Meta-Analysis
Langues
eng
Pagination
1280-1289Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Commentaires et corrections
Type : ErratumIn
Informations de copyright
© The Author(s) 2020. Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine.
Références
BMJ Glob Health. 2018 Nov 5;3(6):e000964
pubmed: 30483412
Bull World Health Organ. 2016 Dec 1;94(12):925-930
pubmed: 27994285
Health Policy Plan. 2017 Oct 1;32(suppl_1):i6-i20
pubmed: 28981766
Lancet. 2014 Jul 26;384(9940):347-70
pubmed: 24853604
PLoS Med. 2015 Sep 29;12(9):e1001881
pubmed: 26418813
Cost Eff Resour Alloc. 2017 Mar 21;15:2
pubmed: 28344517
Health Econ Policy Law. 2016 Oct;11(4):415-32
pubmed: 26906561
JAMA Pediatr. 2013 Sep;167(9):816-25
pubmed: 23689475
Value Health. 2016 Dec;19(8):929-935
pubmed: 27987642
Health Econ. 2016 Feb;25 Suppl 1:53-66
pubmed: 26763594
PLoS One. 2010 Jun 15;5(6):e10313
pubmed: 20559558
PLoS Med. 2012;9(7):e1001257
pubmed: 22802737
Malar J. 2008 Dec 17;7:258
pubmed: 19091114
Health Econ. 2011 Jan;20(1):2-15
pubmed: 21154521
Glob Health Action. 2014 Feb 18;7:23257
pubmed: 24565214
Value Health. 2013 Mar-Apr;16(2):e1-5
pubmed: 23538200
Lancet. 2013 May 18;381(9879):1721-35
pubmed: 23683639
Lancet. 2005 Nov 26;366(9500):1882-4
pubmed: 16310555
Lancet. 2013 May 18;381(9879):1736-46
pubmed: 23683640
Lancet. 2010 Apr 3;375(9721):1193-202
pubmed: 20207412
Lancet. 2010 Apr 3;375(9721):1182-92
pubmed: 20207411
Cost Eff Resour Alloc. 2015 Jan 10;13(1):1
pubmed: 25649323
Int Health. 2013 Sep;5(3):180-95
pubmed: 24030269
Lancet Glob Health. 2016 Jan;4(1):e45-56
pubmed: 26639857
Health Econ. 2016 Feb;25 Suppl 1:140-61
pubmed: 26804361
Lancet. 2004 Sep 11-17;364(9438):970-9
pubmed: 15364188
Int J Epidemiol. 2013 Apr;42(2):520-32
pubmed: 23509239